Global Sexually Transmitted Disease (STD) Diagnosis Market Research Report 2023

Report ID: 1991690 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chlamydia testing
        1.2.3 Syphilis testing
        1.2.4 Gonorrhoea testing
        1.2.5 Herpes simplex virus testing
        1.2.6 Human papilloma virus testing
        1.2.7 Human immunodeficiency virus testing
    1.3 Market by Application
        1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Government organizations
        1.3.3 Hospitals
        1.3.4 Diagnostic clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2017-2028)
    2.2 Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Region
        2.2.1 Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2017-2022)
        2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2023-2028)
    2.3 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
        2.3.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends
        2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
        2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
        2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue
        3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2017-2022)
        3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2017-2022)
    3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
    3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
        3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2021
    3.5 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
    3.6 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
    3.7 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type
    4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2017-2022)
    4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2023-2028)
5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application
    5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2017-2022)
    5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2017-2028)
    6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)
    6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2017-2028)
    7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)
    7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2017-2028)
    8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2017-2028)
    9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)
    9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2017-2028)
    10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Thermo Fisher Scientific
        11.3.1 Thermo Fisher Scientific Company Detail
        11.3.2 Thermo Fisher Scientific Business Overview
        11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.3.5 Thermo Fisher Scientific Recent Development
    11.4 Aposcience
        11.4.1 Aposcience Company Detail
        11.4.2 Aposcience Business Overview
        11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.4.5 Aposcience Recent Development
    11.5 BCR Diagnostics
        11.5.1 BCR Diagnostics Company Detail
        11.5.2 BCR Diagnostics Business Overview
        11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.5.5 BCR Diagnostics Recent Development
    11.6 BD Medical
        11.6.1 BD Medical Company Detail
        11.6.2 BD Medical Business Overview
        11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.6.5 BD Medical Recent Development
    11.7 Biocartis
        11.7.1 Biocartis Company Detail
        11.7.2 Biocartis Business Overview
        11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.7.5 Biocartis Recent Development
    11.8 BioMerieux
        11.8.1 BioMerieux Company Detail
        11.8.2 BioMerieux Business Overview
        11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.8.5 BioMerieux Recent Development
    11.9 Bio-Rad
        11.9.1 Bio-Rad Company Detail
        11.9.2 Bio-Rad Business Overview
        11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.9.5 Bio-Rad Recent Development
    11.10 Cepheid
        11.10.1 Cepheid Company Detail
        11.10.2 Cepheid Business Overview
        11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.10.5 Cepheid Recent Development
    11.11 Danaher
        11.11.1 Danaher Company Detail
        11.11.2 Danaher Business Overview
        11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.11.5 Danaher Recent Development
    11.12 DiaSorin
        11.12.1 DiaSorin Company Detail
        11.12.2 DiaSorin Business Overview
        11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.12.5 DiaSorin Recent Development
    11.13 Quidel
        11.13.1 Quidel Company Detail
        11.13.2 Quidel Business Overview
        11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.13.5 Quidel Recent Development
    11.14 GenMark Diagnostics
        11.14.1 GenMark Diagnostics Company Detail
        11.14.2 GenMark Diagnostics Business Overview
        11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.14.5 GenMark Diagnostics Recent Development
    11.15 Hologic
        11.15.1 Hologic Company Detail
        11.15.2 Hologic Business Overview
        11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.15.5 Hologic Recent Development
    11.16 OraSure Technologies
        11.16.1 OraSure Technologies Company Detail
        11.16.2 OraSure Technologies Business Overview
        11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.16.5 OraSure Technologies Recent Development
    11.17 Qualigen
        11.17.1 Qualigen Company Detail
        11.17.2 Qualigen Business Overview
        11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
        11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
        11.17.5 Qualigen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chlamydia testing
    Table 3. Key Players of Syphilis testing
    Table 4. Key Players of Gonorrhoea testing
    Table 5. Key Players of Herpes simplex virus testing
    Table 6. Key Players of Human papilloma virus testing
    Table 7. Key Players of Human immunodeficiency virus testing
    Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2017-2022)
    Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2023-2028)
    Table 14. Sexually Transmitted Disease (STD) Diagnosis Market Trends
    Table 15. Sexually Transmitted Disease (STD) Diagnosis Market Drivers
    Table 16. Sexually Transmitted Disease (STD) Diagnosis Market Challenges
    Table 17. Sexually Transmitted Disease (STD) Diagnosis Market Restraints
    Table 18. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2017-2022)
    Table 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2021)
    Table 21. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
    Table 25. Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2017-2022)
    Table 29. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2023-2028)
    Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2017-2022)
    Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2023-2028)
    Table 35. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Abbott Company Detail
    Table 46. Abbott Business Overview
    Table 47. Abbott Sexually Transmitted Disease (STD) Diagnosis Product
    Table 48. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 49. Abbott Recent Development
    Table 50. Roche Company Detail
    Table 51. Roche Business Overview
    Table 52. Roche Sexually Transmitted Disease (STD) Diagnosis Product
    Table 53. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Thermo Fisher Scientific Company Detail
    Table 56. Thermo Fisher Scientific Business Overview
    Table 57. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product
    Table 58. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 59. Thermo Fisher Scientific Recent Development
    Table 60. Aposcience Company Detail
    Table 61. Aposcience Business Overview
    Table 62. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product
    Table 63. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 64. Aposcience Recent Development
    Table 65. BCR Diagnostics Company Detail
    Table 66. BCR Diagnostics Business Overview
    Table 67. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
    Table 68. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 69. BCR Diagnostics Recent Development
    Table 70. BD Medical Company Detail
    Table 71. BD Medical Business Overview
    Table 72. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product
    Table 73. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 74. BD Medical Recent Development
    Table 75. Biocartis Company Detail
    Table 76. Biocartis Business Overview
    Table 77. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product
    Table 78. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 79. Biocartis Recent Development
    Table 80. BioMerieux Company Detail
    Table 81. BioMerieux Business Overview
    Table 82. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product
    Table 83. BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 84. BioMerieux Recent Development
    Table 85. Bio-Rad Company Detail
    Table 86. Bio-Rad Business Overview
    Table 87. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product
    Table 88. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 89. Bio-Rad Recent Development
    Table 90. Cepheid Company Detail
    Table 91. Cepheid Business Overview
    Table 92. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product
    Table 93. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 94. Cepheid Recent Development
    Table 95. Danaher Company Detail
    Table 96. Danaher Business Overview
    Table 97. Danaher Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 98. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 99. Danaher Recent Development
    Table 100. DiaSorin Company Detail
    Table 101. DiaSorin Business Overview
    Table 102. DiaSorin Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 103. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 104. DiaSorin Recent Development
    Table 105. Quidel Company Detail
    Table 106. Quidel Business Overview
    Table 107. Quidel Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 108. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 109. Quidel Recent Development
    Table 110. GenMark Diagnostics Company Detail
    Table 111. GenMark Diagnostics Business Overview
    Table 112. GenMark Diagnostics Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 113. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 114. GenMark Diagnostics Recent Development
    Table 115. Hologic Company Detail
    Table 116. Hologic Business Overview
    Table 117. Hologic Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 118. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 119. Hologic Recent Development
    Table 120. OraSure Technologies Company Detail
    Table 121. OraSure Technologies Business Overview
    Table 122. OraSure Technologies Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 123. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 124. OraSure Technologies Recent Development
    Table 125. Qualigen Company Detail
    Table 126. Qualigen Business Overview
    Table 127. Qualigen Sexually Transmitted Disease (STD) DiagnosisProduct
    Table 128. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022) & (US$ Million)
    Table 129. Qualigen Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2021 VS 2028
    Figure 2. Chlamydia testing Features
    Figure 3. Syphilis testing Features
    Figure 4. Gonorrhoea testing Features
    Figure 5. Herpes simplex virus testing Features
    Figure 6. Human papilloma virus testing Features
    Figure 7. Human immunodeficiency virus testing Features
    Figure 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application in 2021 & 2028
    Figure 9. Government organizations Case Studies
    Figure 10. Hospitals Case Studies
    Figure 11. Diagnostic clinics Case Studies
    Figure 12. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered
    Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region: 2021 VS 2028
    Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2021
    Figure 17. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2021
    Figure 19. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2017-2028)
    Figure 21. United States Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2017-2028)
    Figure 25. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2017-2028)
    Figure 33. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2017-2028)
    Figure 41. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2017-2028)
    Figure 45. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Abbott Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 50. Aposcience Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 51. BCR Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 52. BD Medical Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 53. Biocartis Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 54. BioMerieux Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 55. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 56. Cepheid Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 57. Danaher Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 58. DiaSorin Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 59. Quidel Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 60. GenMark Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 61. Hologic Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 62. OraSure Technologies Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 63. Qualigen Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Frequently Asked Questions
Sexually Transmitted Disease (STD) Diagnosis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sexually Transmitted Disease (STD) Diagnosis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sexually Transmitted Disease (STD) Diagnosis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Type 1 Diabetes

Type 1 Diabetes market is segmented by players, region (country), by Type and by Application. Pla ... Read More

UHD Display

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More